RIGL

47.03

0.37% -0.1766

Dopo l'orario di chiusura: 47.38 0.3466 +0.74%

Rigel Pharmaceuticals (RIGL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$47.21

Aprire:

$47.13

Volume 24 ore:

303.39K

Relative Volume:

0.48

Capitalizzazione di mercato:

$855.11M

Reddito:

$116.88M

Utile/perdita netta:

$-25.09M

Rapporto P/E:

-335.95

EPS:

-0.14

Flusso di cassa netto:

$-20.74M

1 W Prestazione:

-7.71%

1M Prestazione:

+65.73%

6M Prestazione:

+128.98%

1 anno Prestazione:

+77.55%

Intervallo 1D:

$46.76

$48.50

Intervallo di 1 settimana:

$43.81

$52.24

Portata 52W:

$14.63

$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Nome

Rigel Pharmaceuticals

Settore

Healthcare (1139)

Industria

Biotechnology (630)

Telefono

650-624-1100

Indirizzo

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Dipendente

164

Cinguettio

@rigelpharma

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

RIGL's Discussions on Twitter

Confronta RIGL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RIGL Rigel Pharmaceuticals	47.11	856.92M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	206.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-05	Aggiornamento	Jefferies	Hold → Buy
2023-04-03	Ripresa	Piper Sandler	Neutral
2022-06-09	Downgrade	Citigroup	Buy → Neutral
2022-06-08	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2022-06-08	Downgrade	Piper Sandler	Overweight → Neutral
2022-03-23	Iniziato	B. Riley Securities	Neutral
2020-11-09	Downgrade	JP Morgan	Overweight → Neutral
2019-11-15	Ripresa	Cantor Fitzgerald	Overweight
2019-09-26	Ripresa	JP Morgan	Overweight
2019-03-01	Reiterato	Cantor Fitzgerald	Overweight
2018-08-27	Iniziato	Citigroup	Buy
2018-05-02	Reiterato	Cantor Fitzgerald	Overweight
2017-12-21	Ripresa	Piper Jaffray	Overweight
2017-12-15	Iniziato	Cantor Fitzgerald	Overweight
2017-11-06	Ripresa	H.C. Wainwright	Buy
2017-03-09	Reiterato	H.C. Wainwright	Buy
2016-08-31	Reiterato	H.C. Wainwright	Buy
2016-08-30	Reiterato	Piper Jaffray	Overweight
2016-07-13	Iniziato	H.C. Wainwright	Buy
2016-06-13	Iniziato	Piper Jaffray	Overweight
2016-04-22	Aggiornamento	JP Morgan	Neutral → Overweight
2013-04-08	Reiterato	Stifel	Buy
2012-11-29	Iniziato	UBS	Neutral
2012-11-06	Reiterato	Oppenheimer	Outperform
2012-03-26	Iniziato	Canaccord Genuity	Hold
2010-12-10	Downgrade	MP Advisors	Outperform → Market Perform

Mostra tutto

Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie

01:51 AM

Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser

01:51 AM

01:43 AM

Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser

01:43 AM

04:40 AM

Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser

04:40 AM

Dec 03, 2025

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Yahoo Finance

Dec 03, 2025

Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025 - Newser

Dec 03, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser

Dec 03, 2025

Dec 02, 2025

(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser

Dec 02, 2025

Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser

Dec 02, 2025

Nov 30, 2025

What analysts say about Rigel Pharmaceuticals Inc RI2 stockVolume Analysis Techniques & Accelerated Financial Growth - earlytimes.in

Nov 30, 2025

Nov 28, 2025

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Nov 28, 2025

Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Nov 28, 2025

Rigel Pharmaceuticals Inc RI2 Stock Analysis and ForecastSmall Cap Stock Opportunities & Discover Your Financial Freedom Formula - earlytimes.in

Nov 28, 2025

Nov 27, 2025

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Nov 27, 2025

Nov 26, 2025